These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15358730)

  • 1. Polyalanine expansions in human.
    Amiel J; Trochet D; Clément-Ziza M; Munnich A; Lyonnet S
    Hum Mol Genet; 2004 Oct; 13 Spec No 2():R235-43. PubMed ID: 15358730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alanine tracts: the expanding story of human illness and trinucleotide repeats.
    Brown LY; Brown SA
    Trends Genet; 2004 Jan; 20(1):51-8. PubMed ID: 14698619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation in polyglutamine diseases.
    Shimohata T; Onodera O; Tsuji S
    Neuropathology; 2000 Dec; 20(4):326-33. PubMed ID: 11211059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyalanine tract disorders and neurocognitive phenotypes.
    Shoubridge C; Gecz J
    Adv Exp Med Biol; 2012; 769():185-203. PubMed ID: 23560312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyalanine and polyserine frameshift products in Huntington's disease.
    Davies JE; Rubinsztein DC
    J Med Genet; 2006 Nov; 43(11):893-6. PubMed ID: 16801344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative toxicity of polyglutamine, polyalanine and polyleucine tracts in Drosophila models of expanded repeat disease.
    van Eyk CL; McLeod CJ; O'Keefe LV; Richards RI
    Hum Mol Genet; 2012 Feb; 21(3):536-47. PubMed ID: 22021427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The other trinucleotide repeat: polyalanine expansion disorders.
    Albrecht A; Mundlos S
    Curr Opin Genet Dev; 2005 Jun; 15(3):285-93. PubMed ID: 15917204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The advances in research on phosphorylation of polyglutamine disease].
    Zhou YF; Jiang H; Tang JG; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):414-7. PubMed ID: 18683139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosomal frameshifting on MJD-1 transcripts with long CAG tracts.
    Toulouse A; Au-Yeung F; Gaspar C; Roussel J; Dion P; Rouleau GA
    Hum Mol Genet; 2005 Sep; 14(18):2649-60. PubMed ID: 16087686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying polyalanine diseases.
    Messaed C; Rouleau GA
    Neurobiol Dis; 2009 Jun; 34(3):397-405. PubMed ID: 19269323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of polyglutamine endolysis followed by pyroglutamate formation in the pathogenesis of triplet repeat/polyglutamine-expansion diseases.
    Saido TC
    Med Hypotheses; 2000 Mar; 54(3):427-9. PubMed ID: 10783480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of HOXA13 polyalanine expansion proteins in hand-foot-genital syndrome.
    Utsch B; McCabe CD; Galbraith K; Gonzalez R; Born M; Dötsch J; Ludwig M; Reutter H; Innis JW
    Am J Med Genet A; 2007 Dec; 143A(24):3161-8. PubMed ID: 17935235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics and biomarkers of polyglutamine diseases.
    Katsuno M; Banno H; Suzuki K; Takeuchi Y; Kawashima M; Tanaka F; Adachi H; Sobue G
    Curr Mol Med; 2008 May; 8(3):221-34. PubMed ID: 18473821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single amino acid and trinucleotide repeats: function and evolution.
    Faux N
    Adv Exp Med Biol; 2012; 769():26-40. PubMed ID: 23560303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyalanine expansion in the ZIC3 gene leading to X-linked heterotaxy with VACTERL association: a new polyalanine disorder?
    Wessels MW; Kuchinka B; Heydanus R; Smit BJ; Dooijes D; de Krijger RR; Lequin MH; de Jong EM; Husen M; Willems PJ; Casey B
    J Med Genet; 2010 May; 47(5):351-5. PubMed ID: 20452998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of polyalanine stretches induces mitochondrial dysfunction.
    Toriumi K; Oma Y; Kino Y; Futai E; Sasagawa N; Ishiura S
    J Neurosci Res; 2008 May; 86(7):1529-37. PubMed ID: 18214990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the molecular basis of polyglutamine neurodegeneration from studies of a spinocerebellar ataxia type 7 mouse model.
    Grote SK; La Spada AR
    Cytogenet Genome Res; 2003; 100(1-4):164-74. PubMed ID: 14526177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deleterious and protective properties of an aggregate-prone protein with a polyalanine expansion.
    Berger Z; Davies JE; Luo S; Pasco MY; Majoul I; O'Kane CJ; Rubinsztein DC
    Hum Mol Genet; 2006 Feb; 15(3):453-65. PubMed ID: 16371423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurodegenerative polyglutamine expansion diseases: physiopathology and therapeutic strategies].
    Ravache M; Abou-Sleymane G; Trottier Y
    Pathol Biol (Paris); 2010 Oct; 58(5):357-66. PubMed ID: 20299163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyglutamine diseases: emerging concepts in pathogenesis and therapy.
    Shao J; Diamond MI
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R115-23. PubMed ID: 17911155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.